unloxcyt

Frequently asked questions

What does Unloxcyt treat?

Unloxcyt (Cosibelimab-Ipdl) may be used to treat squamous cell carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Unloxcyt?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Unloxcyt. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Unloxcyt?

Unloxcyt is marketed by Checkpoint Therapeutics Inc. You can see Checkpoint Therapeutics Inc's full profile, rating, and other products on pharmaranks.

Is Unloxcyt a brand-name or generic drug?

Unloxcyt is a brand-name product with the active ingredient Cosibelimab-Ipdl.

Is Unloxcyt available over the counter?

No. Unloxcyt is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Unloxcyt come in?

Unloxcyt is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Unloxcyt FDA-registered?

Unloxcyt is on record with the U.S. FDA under application number BLA761297. You can verify this on its official FDA label.